PARTNERS CAPITAL INVESTMENT GROUP, LLP - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 10 filers reported holding SEATTLE GENETICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PARTNERS CAPITAL INVESTMENT GROUP, LLP ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q4 2022$5,393,950
-51.4%
41,973
-48.2%
0.26%
-60.6%
Q3 2022$11,097,000
-46.3%
81,103
-30.5%
0.66%
-52.8%
Q2 2022$20,657,000
-12.7%
116,748
-29.0%
1.39%
+19.4%
Q1 2022$23,675,000
+15.1%
164,354
+23.5%
1.16%
+22.2%
Q4 2021$20,577,000
-5.8%
133,098
+3.4%
0.95%
-4.7%
Q3 2021$21,848,000
+15.1%
128,667
+7.0%
1.00%
+18.3%
Q2 2021$18,987,000
+22.9%
120,262
+8.1%
0.84%
+24.6%
Q1 2021$15,455,000
-19.9%
111,300
+1.0%
0.68%
-38.6%
Q4 2020$19,292,000
-26.3%
110,153
-17.7%
1.10%
-31.5%
Q3 2020$26,187,000
+24.5%
133,820
+8.1%
1.61%
+55.8%
Q2 2020$21,027,000
+81.3%
123,748
+23.1%
1.04%
+30.8%
Q1 2020$11,596,000
-31.7%
100,507
-32.3%
0.79%
-38.4%
Q4 2019$16,970,000
+37.1%
148,523
+2.5%
1.28%
+19.4%
Q3 2019$12,375,000
+69.0%
144,904
+37.0%
1.08%
+47.8%
Q2 2019$7,321,000
+3.0%
105,784
+9.0%
0.73%
+3.9%
Q1 2019$7,105,000
+44.7%
97,015
+12.0%
0.70%
+20.2%
Q4 2018$4,910,000
-20.4%
86,652
+8.3%
0.58%
-12.2%
Q3 2018$6,169,000
+33.4%
79,994
+14.8%
0.66%
+11.6%
Q2 2018$4,625,000
+60.0%
69,669
+26.2%
0.60%
+55.8%
Q1 2018$2,890,000
+116.0%
55,223
+120.7%
0.38%
+76.9%
Q4 2017$1,338,00025,0180.22%
Other shareholders
SEATTLE GENETICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Baker Brothers Advisors 50,060,240$5,775,950,00035.57%
Lagoda Investment Management, L.P. 72,969$8,419,0009.97%
Avidity Partners Management LP 580,000$66,920,0009.25%
Arabesque Asset Management Ltd 14,807$1,708,0003.53%
Boxer Capital, LLC 400,000$46,152,0003.15%
Woodline Partners LP 364,333$42,037,0003.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,900$6,557,0002.99%
SECTORAL ASSET MANAGEMENT INC 107,000$12,346,0002.37%
Capital International, Inc./CA/ 1,197,659$138,186,0002.33%
Bain Capital Public Equity Management II, LLC 169,641$19,573,0002.29%
View complete list of SEATTLE GENETICS INC shareholders